PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD
A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent an...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | HE, Xiaolian WANG, Zhenzhong DONG, Xuehong XIAO, Wei WANG, Yanqiu ZHANG, Hui GUO, Qingming GU, Shasha |
description | A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent and a suspending agent, where the suspending agent includes povidone. Furthermore, the pharmaceutical composition is rapid in dissolution, high in stability, simple in preparation process and more suitable for industrialized mass production. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023263789A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023263789A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023263789A13</originalsourceid><addsrcrecordid>eNrjZDAM8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw9HNRCAhyDXAMcgTzfV1DPPxdeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGRsZGZsbmFpaOhMXGqAA2yJ9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD</title><source>esp@cenet</source><creator>HE, Xiaolian ; WANG, Zhenzhong ; DONG, Xuehong ; XIAO, Wei ; WANG, Yanqiu ; ZHANG, Hui ; GUO, Qingming ; GU, Shasha</creator><creatorcontrib>HE, Xiaolian ; WANG, Zhenzhong ; DONG, Xuehong ; XIAO, Wei ; WANG, Yanqiu ; ZHANG, Hui ; GUO, Qingming ; GU, Shasha</creatorcontrib><description>A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent and a suspending agent, where the suspending agent includes povidone. Furthermore, the pharmaceutical composition is rapid in dissolution, high in stability, simple in preparation process and more suitable for industrialized mass production.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230824&DB=EPODOC&CC=US&NR=2023263789A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230824&DB=EPODOC&CC=US&NR=2023263789A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HE, Xiaolian</creatorcontrib><creatorcontrib>WANG, Zhenzhong</creatorcontrib><creatorcontrib>DONG, Xuehong</creatorcontrib><creatorcontrib>XIAO, Wei</creatorcontrib><creatorcontrib>WANG, Yanqiu</creatorcontrib><creatorcontrib>ZHANG, Hui</creatorcontrib><creatorcontrib>GUO, Qingming</creatorcontrib><creatorcontrib>GU, Shasha</creatorcontrib><title>PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD</title><description>A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent and a suspending agent, where the suspending agent includes povidone. Furthermore, the pharmaceutical composition is rapid in dissolution, high in stability, simple in preparation process and more suitable for industrialized mass production.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAM8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw9HNRCAhyDXAMcgTzfV1DPPxdeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGRsZGZsbmFpaOhMXGqAA2yJ9A</recordid><startdate>20230824</startdate><enddate>20230824</enddate><creator>HE, Xiaolian</creator><creator>WANG, Zhenzhong</creator><creator>DONG, Xuehong</creator><creator>XIAO, Wei</creator><creator>WANG, Yanqiu</creator><creator>ZHANG, Hui</creator><creator>GUO, Qingming</creator><creator>GU, Shasha</creator><scope>EVB</scope></search><sort><creationdate>20230824</creationdate><title>PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD</title><author>HE, Xiaolian ; WANG, Zhenzhong ; DONG, Xuehong ; XIAO, Wei ; WANG, Yanqiu ; ZHANG, Hui ; GUO, Qingming ; GU, Shasha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023263789A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HE, Xiaolian</creatorcontrib><creatorcontrib>WANG, Zhenzhong</creatorcontrib><creatorcontrib>DONG, Xuehong</creatorcontrib><creatorcontrib>XIAO, Wei</creatorcontrib><creatorcontrib>WANG, Yanqiu</creatorcontrib><creatorcontrib>ZHANG, Hui</creatorcontrib><creatorcontrib>GUO, Qingming</creatorcontrib><creatorcontrib>GU, Shasha</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HE, Xiaolian</au><au>WANG, Zhenzhong</au><au>DONG, Xuehong</au><au>XIAO, Wei</au><au>WANG, Yanqiu</au><au>ZHANG, Hui</au><au>GUO, Qingming</au><au>GU, Shasha</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD</title><date>2023-08-24</date><risdate>2023</risdate><abstract>A pharmaceutical composition that includes: an active ingredient, including 2-(2-aminopyridine-4-yl)-5-(5-((5-(2-ethyl-2H-tetrazole-5-yl)pyridine-2-yl)-oxy)-3,3-amyldimethyl)-1,2,5-thiadiazolidin 1,1-dioxide or pharmaceutically acceptable salt thereof; and auxiliary materials, including a diluent and a suspending agent, where the suspending agent includes povidone. Furthermore, the pharmaceutical composition is rapid in dissolution, high in stability, simple in preparation process and more suitable for industrialized mass production.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2023263789A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A49%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HE,%20Xiaolian&rft.date=2023-08-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023263789A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |